Lucira is the Next Generation of Infectious Disease Testing 

This test is similar to a PCR test in that it utilises a molecular amplification technology for the detection of SARS-CoV-2 RNA. The test is a multiplexed, isothermal, reverse-transcription loop-mediated amplification (RT-LAMP) test run on a battery-powered, single-use test unit. The SARS-CoV-2 primer sets are designed to detect RNA of the N gene and Orf 7b/8 gene for SARS-CoV-2 virus in self-collected nasal swab samples tested with the Test Unit.  

Lucira Platform diagnostic technology is:

  • Fast - Positive results in as few as 11 minutes; negative results in 30 minutes
  • Untethered - No instrument, reader, plug, or connectivity needed